Advertisement

World Journal of Surgery

, Volume 41, Issue 7, pp 1685–1690 | Cite as

Surgical Treatment of Gastroesophageal Reflux Disease

  • Francisco Schlottmann
  • Fernando A. Herbella
  • Marco E. Allaix
  • Fabrizio Rebecchi
  • Marco G. Patti
Surgical Symposium Contribution

Abstract

Background

Gastroesophageal reflux disease (GERD) affects an estimated 20% of the population in the USA, and its prevalence is increasing worldwide. Lifestyle modifications and proton pump inhibitors (PPI) therapy are effective in the majority of patients and remain the mainstay of treatment of GERD. However, some patients will need surgical intervention because they have partial control of symptoms, do not want to be on long-term medical treatment, or suffer complications related to PPI therapy.

Aims

The aim of this study was to review the available evidence that supports laparoscopic antireflux surgery, and to study the effect of surgical therapy on the natural history of GERD.

Results

The key elements for the success of antireflux surgery are proper patient selection, careful analysis of the indications for surgery, complete pre-operative work-up, and proper execution of the surgical technique.

Conclusions

When the key elements are respected, antireflux surgery is very effective in controlling GERD, and it is associated to minimal morbidity and mortality.

Keywords

Lower Esophageal Sphincter Clostridium Difficile Infection Eosinophilic Esophagitis Proton Pump Inhibitor Therapy Laparoscopic Fundoplication 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Conflict of interest

The authors have no conflict of interest to declare.

References

  1. 1.
    El-Serag HN, Sweet S, Winchester CC et al (2014) Update on the epidemiology of gastro-esophageal reflux disease: a systematic review. Gut 63:871–880CrossRefPubMedGoogle Scholar
  2. 2.
    Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R (2002) The burden of selected digestive diseases in the United States. Gastroenterology 122:1500–1511CrossRefPubMedGoogle Scholar
  3. 3.
    Shaheen NJ, Hansen RA, Morgan DR et al (2006) The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol 101(9):2128–2138CrossRefPubMedGoogle Scholar
  4. 4.
    Joish VN, Donaldson G, Stockdale W et al (2005) The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 21(4):535–544CrossRefPubMedGoogle Scholar
  5. 5.
    Johnson LF, DeMeester TR (1986) Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol 8:52–58CrossRefPubMedGoogle Scholar
  6. 6.
    Gerson LB, Kahrilas PJ, Fass R (2011) Insights into gastroesophageal reflux diseases–associated dyspeptic symptoms. Clin Gastroenterol Hepatol 9:824–833CrossRefPubMedGoogle Scholar
  7. 7.
    Lacy BE, Talley NJ, Locke GR et al (2012) Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther 36:3–15CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Patti MG, Diener U, Tamburini A, Molena D, Way LW (2001) Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci 46(3):597–602CrossRefPubMedGoogle Scholar
  9. 9.
    Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, DeVault K, Fass R, Gyawali CP, Kahrilas PJ, Lacy BE, Pandolfino JE, Patti MG, Swanstrom LL, Kurian AA, Vela MF, Vaezi M, DeMeester TR (2013) Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg 217(4):586–597CrossRefPubMedGoogle Scholar
  10. 10.
    Sonnenberg A, Delcò F, El-Serag HB (1998) Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci 43(5):1001–1008CrossRefPubMedGoogle Scholar
  11. 11.
    Ates F, Vaezi MF (2014) New approaches to management of PPI-refractory gastroesophageal reflux disease. Curr Treat Options Gastroenterol. 12(1):18–33CrossRefPubMedGoogle Scholar
  12. 12.
    Nasseri-Moghaddam S, Razjouyan H, Nouraei M et al (2007) Inter and intra-observer variability of the Los Angeles classification: a reassessment. Arch Iran Med 10:48–53PubMedGoogle Scholar
  13. 13.
    Bello B, Zoccali M, Gullo R, Allaix ME, Herbella FA, Gasparitis A et al (2013) Gastroesophageal reflux disease and antireflux surgery—what is the proper preoperative work-up? J Gastrointest Surg 17:14–20CrossRefPubMedGoogle Scholar
  14. 14.
    Fisichella PM, Patti MG (2014) GERD procedures: when and what? J Gastrointest Surg 18:2047–2053CrossRefPubMedGoogle Scholar
  15. 15.
    Patti MG, Gasper WJ, Fisichella PM, Nipomnick I, Palazzo F (2008) Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment. J Gastrointest Surg 12:1900–1906CrossRefPubMedGoogle Scholar
  16. 16.
    Broeders JA, Sportel IG, Jamieson GG, Nijjar RS, Granchi N, Myers JC, Thompson SK (2011) Impact of ineffective oesophageal motility and wrap type on dysphagia after laparoscopic fundoplication. Br J Surg 98:1414–1421CrossRefPubMedGoogle Scholar
  17. 17.
    Hirano I, Richter JE (2007) Practice parameters committee of the American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol 102(3):668–685CrossRefPubMedGoogle Scholar
  18. 18.
    Wiener GJ, Morgan TM, Cooper JB et al (1988) Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 33:1127–1133CrossRefPubMedGoogle Scholar
  19. 19.
    Weusten BL, Roelofs JM, Akkermans LM et al (1994) The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 107:1741–1745CrossRefPubMedGoogle Scholar
  20. 20.
    Agrawal A, Castell DO (2008) Clinical importance of impedance measurements. J Clin Gastroenterol 42:579–583CrossRefPubMedGoogle Scholar
  21. 21.
    Vela MF (2009) Non-acid reflux: detection by multichannel intraluminal impedance and pH, clinical significance and management. Am J Gastroenterol 104:277–280CrossRefPubMedGoogle Scholar
  22. 22.
    Francis DO, Goutte M, Slaughter JC et al (2011) Traditional reflux parameters and not impedance monitoring predict outcome after fundoplication in extraesophageal reflux. Laryngoscope 121:1902–1909CrossRefPubMedGoogle Scholar
  23. 23.
    Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S, DeMeester SR, Hagen JA, Bremner CG (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3(3):292–300CrossRefPubMedGoogle Scholar
  24. 24.
    Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD (2007) Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 21:1978–1984CrossRefPubMedGoogle Scholar
  25. 25.
    Koch OO, Kaindlstorfer A, Antoniou SA, Asche KU, Granderath FA, Pointner R (2012) Influence of the esophageal hiatus size on the lower esophageal sphincter, on reflux activity and on symptomatology. Dis Esophagus 25(3):201–208CrossRefPubMedGoogle Scholar
  26. 26.
    Coron E, Hatlebakk JG, Galmiche JP (2007) Medical therapy of gastroesophageal reflux disease. Curr Opin Gastroenterol 23(4):434–439PubMedGoogle Scholar
  27. 27.
    Van Soest EM, Siersema PD, Dieleman JP, Sturkenboom MC, Kuipers EJ (2006) Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 24(2):377–385CrossRefPubMedGoogle Scholar
  28. 28.
    Hungin AP, Rubin G, O’Flanagan H (1999) Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 49(443):463–464PubMedPubMedCentralGoogle Scholar
  29. 29.
    Faria R, Bojke L, Epstein D, Corbacho B, Sculpher M, REFLUX trial group (2013) Cost-effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of gastro-oesophageal reflux disease based on long-term follow-up of the REFLUX trial. Br J Surg 100(9):1205–1213CrossRefPubMedGoogle Scholar
  30. 30.
    Anderson WD III, Strayer SM, Mull SR (2015) Common questions about the management of gastroesophageal reflux disease. Am Fam Physician 91(10):692–697PubMedGoogle Scholar
  31. 31.
    Sukhovershin RA, Cooke JP (2016) How may proton pump inhibitors impair cardiovascular health? Am J Cardiovasc Drugs 16:153–161CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Booth MI, Stratford J, Jones L, Dehn TC (2008) Randomized clinical trial of laparoscopic total (Nissen) versus posterior partial (Toupet) fundoplication for gastro-oesophageal reflux disease based on preoperative oesophageal manometry. Br J Surg 95(1):57–63CrossRefPubMedGoogle Scholar
  33. 33.
    Cai W, Watson DI, Lally CJ, Devitt PG, Game PA, Jamieson GG (2008) Ten-year clinical outcome of a prospective randomized clinical trial of laparoscopic Nissen versus anterior 180 (degrees) partial fundoplication. Br J Surg 95(12):1501–1505CrossRefPubMedGoogle Scholar
  34. 34.
    Shan CX, Zhang W, Zheng XM, Jiang DZ, Liu S, Qiu M (2010) Evidence-based appraisal in laparoscopic Nissen and Toupet fundoplications for gastroesophageal reflux disease. World J Gastroenterol 16(24):3063–3071CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Patterson EJ, Herron DM, Hansen PD et al (2000) Effect of an esophageal bougie on the incidence of dysphagia following Nissen fundoplication: a prospective, blinded, randomized clinical trial. Arch Surg 135(9):1055–1061CrossRefPubMedGoogle Scholar
  36. 36.
    Patti MG, Gasper WJ, Fisichella PM, Nipomnick I, Palazzo F (2008) Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment. J Gastrointest Surg 12(11):1900–1906CrossRefPubMedGoogle Scholar
  37. 37.
    Makris KI, Cassera MA, Kastenmeier AS, Dunst CM, Swanström LL (2012) Postoperative dysphagia is not predictive of long-term failure after laparoscopic antireflux surgery. Surg Endosc 26(2):451–457CrossRefPubMedGoogle Scholar
  38. 38.
    Kessing BF, Broeders JA, Vinke N, Schijven MP, Hazebroek EJ, Broeders IA, Bredenoord AJ, Smout AJ (2013) Gas-related symptoms after antireflux surgery. Surg Endosc 27(10):3739–3747CrossRefPubMedGoogle Scholar
  39. 39.
    Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L, LOTUS Trial Collaborators (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. Jama 305(19):1969–1977CrossRefPubMedGoogle Scholar
  40. 40.
    Broeders JA, Bredenoord AJ, Hazebroek EJ, Broeders IA, Gooszen HG, Smout AJ (2012) Reflux and belching after 270 degree versus 360 degree laparoscopic posterior fundoplication. Ann Surg 255(1):59–65CrossRefPubMedGoogle Scholar
  41. 41.
    Caldarella MP, Serra J, Azpiroz F, Malagelada JR (2002) Prokinetic effects in patients with intestinal gas retention. Gastroenterology 122(7):1748–1755CrossRefPubMedGoogle Scholar
  42. 42.
    Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, Jehaes C (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20(1):159–165CrossRefPubMedGoogle Scholar
  43. 43.
    Broeders JA, Rijnhart-de Jong HG, Draaisma WA, Bredenoord AJ, Smout AJ, Gooszen HG (2009) Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial. Ann Surg 250(5):698–706CrossRefPubMedGoogle Scholar
  44. 44.
    Morgenthal CB, Shane MD, Stival A, Gletsu N, Milam G, Swafford V, Hunter JG, Smith CD (2007) The durability of laparoscopic Nissen fundoplication: 11-year outcomes. J Gastrointest Surg 11(6):693–700CrossRefPubMedGoogle Scholar
  45. 45.
    Robinson B, Dunst CM, Cassera MA, Reavis KM, Sharata A, Swanstrom LL (2015) 20 years later: laparoscopic fundoplication durability. Surg Endosc 29:2520–2524CrossRefPubMedGoogle Scholar
  46. 46.
    Galvani C, Fisichella PM, Gorodner MV, Perretta S, Patti MG (2003) Symptoms are a poor indicator of reflux status after fundoplication for gastroesophageal reflux disease: role of esophageal functions tests. Arch Surg 138(5):514–518CrossRefPubMedGoogle Scholar
  47. 47.
    Davis CS, Baldea A, Johns JR, Joehl RJ, Fisichella PM (2010) The evolution and long-term results of laparoscopic antireflux surgery for the treatment of gastroesophageal reflux disease. J Soc Laparoendosc Surg 14(3):332–341CrossRefGoogle Scholar
  48. 48.
    Horgan S, Pohl D, Bogetti D, Eubanks T, Pellegrini C (1999) Failed antireflux surgery: what have we learned from reoperations? Arch Surg 134(8):809–815CrossRefPubMedGoogle Scholar
  49. 49.
    Wang YR, Dempsey DT, Richter JE (2011) Trends and perioperative outcomes of inpatient antireflux surgery in the United States, 1993–2006. Dis Esophagus 24(4):215–223CrossRefPubMedGoogle Scholar
  50. 50.
    Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R (2016) Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther 43(11):1124–1131CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2017

Authors and Affiliations

  • Francisco Schlottmann
    • 1
  • Fernando A. Herbella
    • 2
  • Marco E. Allaix
    • 3
  • Fabrizio Rebecchi
    • 3
  • Marco G. Patti
    • 1
  1. 1.Department of Surgery and Center for Esophageal Diseases and SwallowingUniversity of North CarolinaChapel HillUSA
  2. 2.Department of Surgery, Escola Paulista de MedicinaFederal University of São PauloSão PauloBrazil
  3. 3.Department of Surgical SciencesUniversity of TorinoTurinItaly

Personalised recommendations